Indication
Excoriation disorder
2 clinical trials
2 products
Clinical trial
Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive BehaviorsStatus: Recruiting, Estimated PCD: 2024-06-01
Product
MemantineClinical trial
A Double Blind, Placebo Controlled, Fixed-Flexible Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2024-01-18
Product
Guanfacine